Aptorum Group Ltd logo

Aptorum Group Ltd

$ 0.49 -0.0564 (-10.26%) 10:08 PM EST
P/E:
At Loss
P/B:
0.78
Market Cap:
$ 17.61M
Enterprise V:
$ 18.93M
Volume:
19.57K
Avg Vol (2M):
59.06K
Also Trade In:
Volume:
19.57K
Market Cap $:
17.61M
PE Ratio:
At Loss
Avg Vol (2-Month):
59.06K
Enterprise Value $:
18.93M
PB Ratio:
0.78
GF Score:
Year:
Not Enough Data to Display
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Not Enough Data to Display
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in two segments: Therapeutics and Non-Therapeutics. Its lead projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.
Name Current Vs Industry Vs History
Cash-To-Debt 1.2
Equity-to-Asset 0.94
Debt-to-Equity 0.16
Debt-to-EBITDA -0.14
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -4.42
Distress
Grey
Safe
Beneish M-Score 1.11
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 25.31
9-Day RSI 30.59
14-Day RSI 32.99
6-1 Month Momentum % -45.43
12-1 Month Momentum % -59.89

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.14
Quick Ratio 1.13
Cash Ratio 0.51
Days Inventory 8.86
Days Sales Outstanding 16.83

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -7.1

Financials (Next Earnings Date:2023-04-28 Est.)

APM's 30-Y Financials

Guru Trades

See Details
To
Not Enough Data to Display

Insider Trades

See Details
To
Not Enough Data to Display

Gurus Latest Trades with NAS:APM

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
Not Enough Data to Display

Performance

Dividend
Log
To
Not Enough Data to Display

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Not Enough Data to Display

Valuation Box

Year:
Not Enough Data to Display

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 1.431
EPS (TTM) ($) -0.29
Beta 0.71
Volatility % 77.59
14-Day RSI 32.99
14-Day ATR ($) 0.079917
20-Day SMA ($) 0.596071
12-1 Month Momentum % -59.89
52-Week Range ($) 0.48 - 2.35
Shares Outstanding (Mil) 35.71

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Aptorum Group Ltd Filings

Document Form Filing Date
No Filing Data

Aptorum Group Ltd Analysis

Share your research

Headlines

See More
No news.